https://vhio.net/2022-06-30always0.5 https://vhio.net/es/inicio/2022-06-30always0.5 https://vhio.net/ca/inici/2022-06-30always0.5 https://vhio.net/the-institute/2022-06-30always0.5 https://vhio.net/trustees/2022-06-30always0.5 https://vhio.net/board-of-trustees/2022-06-30always0.5 https://vhio.net/boards-executive-committee/2022-06-30always0.5 https://vhio.net/vhios-scientific-advisory-board-sab/2022-06-30always0.5 https://vhio.net/internal-scientific-committee/2022-06-30always0.5 https://vhio.net/leadership/2022-06-30always0.5 https://vhio.net/management-and-support-areas/2022-06-30always0.5 https://vhio.net/scientific-coordination-area/2022-06-30always0.5 https://vhio.net/organizational-chart/2022-06-30always0.5 https://vhio.net/institutional-programs-bbva/2022-06-30always0.5 https://vhio.net/institutional-programs-la-caixa/2022-06-30always0.5 https://vhio.net/jose-baselga-innovative-disruption-program/2022-06-30always0.5 https://vhio.net/institutional-programs-fero/2022-06-30always0.5 https://vhio.net/international-consortia/2022-06-30always0.5 https://vhio.net/national-consortia/2022-06-30always0.5 https://vhio.net/vall-dhebron-campus/2022-06-30always0.5 https://vhio.net/membership/2022-06-30always0.5 https://vhio.net/green-vhio/2022-06-30always0.5 https://vhio.net/quality-assurance/2022-06-30always0.5 https://vhio.net/about-cancer/2022-06-30always0.5 https://vhio.net/preclinical-and-translational-research/2022-06-30always0.5 https://vhio.net/contact/2022-06-30always0.5 https://vhio.net/annual-scientific-report/2022-06-30always0.5 https://vhio.net/pf/noncolorectal-gastrointestinal-cancer-translational-research-group/2022-06-30always0.5 https://vhio.net/pf/experimental-therapeutics-group/2022-06-30always0.5 https://vhio.net/pf/gene-expression-and-cancer-group/2022-06-30always0.5 https://vhio.net/pf/growth-factors-group/2022-06-30always0.5 https://vhio.net/pf/models-of-cancer-therapies-group/2022-06-30always0.5 https://vhio.net/pf/prostate-cancer-translational-research-group/2022-06-30always0.5 https://vhio.net/pf/sarcoma-translational-research-group/2022-06-30always0.5 https://vhio.net/pf/stem-cells-cancer-group/2022-06-30always0.5 https://vhio.net/pf/tumor-biomarkers-group/2022-06-30always0.5 https://vhio.net/pf/tumor-immunology-immunotherapy-group/2022-06-30always0.5 https://vhio.net/clinical-research/2022-06-30always0.5 https://vhio.net/pf/breast-cancer-and-melanoma-group/2022-06-30always0.5 https://vhio.net/pf/early-clinical-drug-development-group/2022-06-30always0.5 https://vhio.net/pf/experimental-hematology-group/2022-06-30always0.5 https://vhio.net/pf/gastrointestinal-and-endocrine-tumors-group/2022-06-30always0.5 https://vhio.net/pf/genitourinary-central-nervous-system-cns-tumors-sarcoma-and-cancer-of-unknown-primary-site-group/2022-06-30always0.5 https://vhio.net/pf/gynecological-malignancies-group/2022-06-30always0.5 https://vhio.net/pf/hereditary-cancer-genetics-group/2022-06-30always0.5 https://vhio.net/pf/oncology-data-science-odyssey-group/2022-06-30always0.5 https://vhio.net/pf/radiation-oncology-group/2022-06-30always0.5 https://vhio.net/pf/radiomics-group/2022-06-30always0.5 https://vhio.net/pf/thoracic-tumors-head-and-neck-cancer-group/2022-06-30always0.5 https://vhio.net/core-technologies/2022-06-30always0.5 https://vhio.net/pf/bioinformatics-unit/2022-06-30always0.5 https://vhio.net/pf/cancer-genomics-group/2022-06-30always0.5 https://vhio.net/pf/molecular-oncology-group/2022-06-30always0.5 https://vhio.net/pf/proteomics-group/2022-06-30always0.5 https://vhio.net/researchers/2022-06-30always0.5 https://vhio.net/task-forces-model/2022-06-30always0.5 https://vhio.net/technology-transfer/2022-06-30always0.5 https://vhio.net/our-research/2022-06-30always0.5 https://vhio.net/clinical-trials-office/2022-06-30always0.5 https://vhio.net/academic-cro/2022-06-30always0.5 https://vhio.net/research-unit-for-molecular-therapy-of-cancer-uitm-caixaresearch/2022-06-30always0.5 https://vhio.net/prescreening-program/2022-06-30always0.5 https://vhio.net/clinical-research-oncology-nurses/2022-06-30always0.5 https://vhio.net/clinical-research-oncology-pharmacy-unit/2022-06-30always0.5 https://vhio.net/quality-and-processes-unit/2022-06-30always0.5 https://vhio.net/working-at-vhio/2022-06-30always0.5 https://vhio.net/job-opportunities/2022-06-30always0.5 https://vhio.net/career-development/2022-06-30always0.5 https://vhio.net/hrs4r/2022-06-30always0.5 https://vhio.net/equality-plan/2022-06-30always0.5 https://vhio.net/the-vhio-academy/2022-06-30always0.5 https://vhio.net/vhio-fellowships/2022-06-30always0.5 https://vhio.net/continuous-learning/2022-06-30always0.5 https://vhio.net/news/2022-06-30always0.5 https://vhio.net/vhio-in-the-media/2022-06-30always0.5 https://vhio.net/corporate-information/2022-06-30always0.5 https://vhio.net/events/2022-06-30always0.5 https://vhio.net/patients/2022-06-30always0.5 https://vhio.net/outreach-activities/2022-06-30always0.5 https://vhio.net/severo-ochoa/2022-06-30always0.5 https://vhio.net/2022/06/21/checkmate-9er-extended-follow-up-data-further-supports-nivolumab-plus-cabozantinib-as-first-line-treatment-of-advanced-renal-cell-carcinoma/2022-06-30always0.5 https://vhio.net/2022/06/15/astrazeneca-and-vhio-launch-a-program-to-promote-preclinical-and-translational-research/2022-06-30always0.5 https://vhio.net/2022/06/10/vhio-authored-comment-extending-the-promise-of-combinatorial-immunotherapy-in-metastatic-colorectal-cancer/2022-06-30always0.5 https://vhio.net/2022/06/09/novel-brain-permeable-braf-inhibitor-shows-promise-in-more-effectively-reaching-and-treating-melanoma-brain-metastasis/2022-06-30always0.5 https://vhio.net/pf/cellular-plasticity-and-cancer-group/2022-06-30always0.5 https://vhio.net/pf/cancer-computational-biology-group/2022-06-30always0.5 https://vhio.net/pf/vhioteca/2022-06-30always0.5 https://vhio.net/biosketch-francesc-bosch/2022-06-30always0.5 https://vhio.net/biosketch-teresa-macarulla/2022-06-30always0.5 https://vhio.net/biosketch-joaquin-arribas/2022-06-30always0.5 https://vhio.net/biosketch-raquel-perez-lopez/2022-06-30always0.5 https://vhio.net/events__/direna-alonso-i-epigenetic-licensing-of-tumor-promoting-inflammation-in-pancreatic-cancer-2/2022-06-30always0.5 https://vhio.net/events__/andrew-tutt-4/2022-06-30always0.5 https://vhio.net/events__/andrew-tutt-2/2022-06-30always0.5 https://vhio.net/events__/sara-sdelci-loxl2-aids-the-formation-of-brd4s-and-med1-transcriptional-foci-to-control-cell-cycle-gene-expression-in-triple-negative-breast-cancer-2/2022-06-30always0.5 https://vhio.net/vhio-caixaresearch-scientific-seminars-series/2022-06-30always0.5 https://vhio.net/benchstorming-seminars/2022-06-30always0.5 https://vhio.net/courses-and-workshops/2022-06-30always0.5 https://vhio.net/transparency-portal/2022-06-30always0.5 https://vhio.net/legal-advice/2022-06-30always0.5 https://vhio.net/es/el-instituto/2022-06-30always0.5 https://vhio.net/es/patronos/2022-06-30always0.5 https://vhio.net/es/patronato/2022-06-30always0.5 https://vhio.net/es/comite-ejecutivo-del-patronato/2022-06-30always0.5 https://vhio.net/es/consejo-cientifico-asesor-del-vhio-cca/2022-06-30always0.5 https://vhio.net/es/comite-cientifico-interno/2022-06-30always0.5 https://vhio.net/es/liderazgo/2022-06-30always0.5 https://vhio.net/es/areas-de-gestion-y-apoyo/2022-06-30always0.5 https://vhio.net/es/area-de-coordinacion-cientifica/2022-06-30always0.5 https://vhio.net/es/organigrama-2/2022-06-30always0.5 https://vhio.net/es/fundacion-la-caixa/2022-06-30always0.5 https://vhio.net/es/programas-institucionales-bbva/2022-06-30always0.5 https://vhio.net/es/programa-de-diagnostico-molecular-avanzado-diamav-de-la-fundacion-fero/2022-06-30always0.5 https://vhio.net/es/jose-baselga-innovative-disruption-program-2/2022-06-30always0.5 https://vhio.net/es/consorcios-internacionales/2022-06-30always0.5 https://vhio.net/es/consorcios-nacionales/2022-06-30always0.5 https://vhio.net/es/afiliacion/2022-06-30always0.5 https://vhio.net/es/campus-vall-dhebron/2022-06-30always0.5 https://vhio.net/es/sobre-el-cancer/2022-06-30always0.5 https://vhio.net/es/politica-de-calidad/2022-06-30always0.5 https://vhio.net/es/green-vhio-2/2022-06-30always0.5 https://vhio.net/es/informe-cientifico-anual/2022-06-30always0.5 https://vhio.net/es/contacto/2022-06-30always0.5 https://vhio.net/es/investigacion-preclinica-y-traslacional/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-investigacion-traslacional-del-cancer-gastrointestinal-no-colorrectal/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-terapeutica-experimental/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-expresion-genica-y-cancer/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-factores-de-crecimiento/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-modelizacion-de-terapias-antitumorales/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-investigacion-traslacional-en-cancer-de-prostata/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-investigacion-traslacional-del-sarcoma/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-celulas-madre-y-cancer/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-los-biomarcadores-tumorales/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-inmunoterapia-e-inmunologia-de-tumores/2022-06-30always0.5 https://vhio.net/es/investigacion-clinica/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-cancer-de-mama-y-melanoma/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-desarrollo-clinico-precoz-de-farmacos/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-hematologia-experimental/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-tumores-gastrointestinales-y-endocrinos/2022-06-30always0.5 https://vhio.net/es/pf/grupo-del-programa-de-tumores-genitourinarios-del-snc-y-sarcoma/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-neoplasias-ginecologicas/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-genetica-del-cancer-hereditario/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-oncology-data-science-odyssey/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-oncologia-radioterapica/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-radiomica/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-tumores-toracicos-y-cancer-de-cabeza-y-cuello/2022-06-30always0.5 https://vhio.net/es/tecnologias-trasversales/2022-06-30always0.5 https://vhio.net/es/pf/unidad-de-bioinformatica/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-genomica-del-cancer/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-oncologia-molecular/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-proteomica/2022-06-30always0.5 https://vhio.net/es/pf/vhioteca-2/2022-06-30always0.5 https://vhio.net/es/investigadores/2022-06-30always0.5 https://vhio.net/es/modelo-de-grupos-de-trabajo/2022-06-30always0.5 https://vhio.net/es/transferencia-de-tecnologia-2/2022-06-30always0.5 https://vhio.net/es/nuestra-investigacion/2022-06-30always0.5 https://vhio.net/es/oficina-de-ensayos-clinicos/2022-06-30always0.5 https://vhio.net/es/cro-academica-2/2022-06-30always0.5 https://vhio.net/es/unidad-de-investigacion-de-terapia-molecular-del-cancer-uitm-caixaresearch/2022-06-30always0.5 https://vhio.net/es/programa-de-preseleccion/2022-06-30always0.5 https://vhio.net/es/enfermeras-de-investigacion-clinica-oncologica/2022-06-30always0.5 https://vhio.net/es/unidad-de-atencion-farmaceutica-de-oncologia/2022-06-30always0.5 https://vhio.net/es/unidad-de-calidad-y-procesos/2022-06-30always0.5 https://vhio.net/es/trabajar-en-vhio/2022-06-30always0.5 https://vhio.net/es/oportunidades-de-empleo/2022-06-30always0.5 https://vhio.net/es/desarrollo-profesional/2022-06-30always0.5 https://vhio.net/es/hrs4r-3/2022-06-30always0.5 https://vhio.net/es/plan-de-igualdad/2022-06-30always0.5 https://vhio.net/es/la-vhio-academy/2022-06-30always0.5 https://vhio.net/es/becas-del-vhio/2022-06-30always0.5 https://vhio.net/es/aprendizaje-continuo/2022-06-30always0.5 https://vhio.net/es/noticias/2022-06-30always0.5 https://vhio.net/es/vhio-en-los-medios/2022-06-30always0.5 https://vhio.net/es/informacion-corporativa/2022-06-30always0.5 https://vhio.net/es/eventos/2022-06-30always0.5 https://vhio.net/es/pacientes/2022-06-30always0.5 https://vhio.net/es/actividades-outreach/2022-06-30always0.5 https://vhio.net/es/severo-ochoa-2/2022-06-30always0.5 https://vhio.net/es/2022/06/30/vall-dhebron-trata-al-primer-paciente-con-una-terapia-celular-propia-basada-en-celulas-til-un-tratamiento-experimental-contra-el-cancer/2022-06-30always0.5 https://vhio.net/es/2022/06/21/el-dr-josep-tabernero-recibe-el-premio-de-investigacion-biomedica-2022-de-la-fundacion-lilly/2022-06-30always0.5 https://vhio.net/es/2022/06/15/astrazeneca-y-vhio-ponen-en-marcha-un-programa-para-favorecer-la-investigacion-preclinica-y-traslacional/2022-06-30always0.5 https://vhio.net/es/2022/06/10/vall-dhebron-participa-en-un-estudio-para-identificar-un-biomarcador-especifico-y-diana-terapeutica-en-cancer-de-mama-her2/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-la-plasticidad-celular-y-cancer/2022-06-30always0.5 https://vhio.net/es/pf/grupo-de-biologia-computacional-del-cancer/2022-06-30always0.5 https://vhio.net/biosketch-cristina-saura/2022-06-30always0.5 https://vhio.net/biosketch-elena-garralda/2022-06-30always0.5 https://vhio.net/es/events__/direna-alonso-i-epigenetic-licensing-of-tumor-promoting-inflammation-in-pancreatic-cancer-3/2022-06-30always0.5 https://vhio.net/es/events__/andrew-tutt-5/2022-06-30always0.5 https://vhio.net/es/events__/andrew-tutt-3/2022-06-30always0.5 https://vhio.net/es/events__/sara-sdelci-loxl2-aids-the-formation-of-brd4s-and-med1-transcriptional-foci-to-control-cell-cycle-gene-expression-in-triple-negative-breast-cancer-3/2022-06-30always0.5 https://vhio.net/es/campus-vall-dhebron-3/2022-06-30always0.5 https://vhio.net/es/portal-de-transparencia/2022-06-30always0.5 https://vhio.net/es/aviso-legal/2022-06-30always0.5 https://vhio.net/shop/2022-06-30always0.5 https://vhio.net/ca/la-institucio/2022-06-30always0.5 https://vhio.net/ca/patrons/2022-06-30always0.5 https://vhio.net/ca/patronat/2022-06-30always0.5 https://vhio.net/ca/comite-executiu-del-patronat/2022-06-30always0.5 https://vhio.net/ca/consell-cientific-assessor-del-vhio-cca/2022-06-30always0.5 https://vhio.net/ca/comite-cientific-intern/2022-06-30always0.5 https://vhio.net/ca/lideratge/2022-06-30always0.5 https://vhio.net/ca/arees-de-gestio-i-suport/2022-06-30always0.5 https://vhio.net/ca/area-de-coordinacio-cientifica/2022-06-30always0.5 https://vhio.net/ca/organigrama/2022-06-30always0.5 https://vhio.net/ca/programa-de-recerca-oncologica-avancada-de-caixaresearch/2022-06-30always0.5 https://vhio.net/ca/programa-integral-dimmunoterapia-i-immunologia-del-cancer-caimi-de-la-fundacio-bbva/2022-06-30always0.5 https://vhio.net/ca/programa-de-diagnostic-molecular-avancat-diamav-de-la-fundacio-fero/2022-06-30always0.5 https://vhio.net/ca/jose-baselga-innovative-disruption-program-3/2022-06-30always0.5 https://vhio.net/ca/consorcis-internacionals/2022-06-30always0.5 https://vhio.net/ca/consorcis-nacionals/2022-06-30always0.5 https://vhio.net/ca/afiliacio/2022-06-30always0.5 https://vhio.net/ca/campus-vall-dhebron-3-2/2022-06-30always0.5 https://vhio.net/ca/sobre-el-cancer-2/2022-06-30always0.5 https://vhio.net/ca/politica-de-qualitat/2022-06-30always0.5 https://vhio.net/ca/green-vhio-3/2022-06-30always0.5 https://vhio.net/ca/informe-cientific-anual/2022-06-30always0.5 https://vhio.net/ca/contacte/2022-06-30always0.5 https://vhio.net/ca/recerca-preclinica-i-tranlacional/2022-06-30always0.5 https://vhio.net/ca/pf/grup-de-biologia-computacional-del-cancer/2022-06-30always0.5 https://vhio.net/ca/pf/grup-de-la-plasticitat-cellular-i-cancer/2022-06-30always0.5 https://vhio.net/ca/pf/grup-de-terapeutica-experimental/2022-06-30always0.5 https://vhio.net/ca/pf/grup-dexpressio-genica-i-cancer/2022-06-30always0.5 https://vhio.net/ca/pf/grup-de-factors-de-creixement/2022-06-30always0.5 https://vhio.net/ca/pf/grup-de-modelitzacio-de-terapies-antitumorals/2022-06-30always0.5 https://vhio.net/ca/pf/grup-de-recerca-translacional-en-cancer-de-prostata/2022-06-30always0.5 https://vhio.net/ca/pf/grup-de-recerca-translacional-del-sarcoma/2022-06-30always0.5 https://vhio.net/ca/pf/grup-de-cellules-mare-i-cancer/2022-06-30always0.5 https://vhio.net/ca/pf/grup-dels-biomarcadors-tumorals/2022-06-30always0.5 https://vhio.net/ca/pf/grup-dimmunoterapia-i-immunologia-de-tumors/2022-06-30always0.5 https://vhio.net/ca/recerca-clinica/2022-06-30always0.5 https://vhio.net/ca/pf/grup-de-cancer-de-mama-i-melanoma/2022-06-30always0.5 https://vhio.net/ca/pf/grup-de-desenvolupament-clinic-precoc-de-farmacs/2022-06-30always0.5 https://vhio.net/ca/pf/grup-dhematologia-experimental/2022-06-30always0.5 https://vhio.net/ca/pf/grup-de-tumors-gastrointestinals-i-endocrins/2022-06-30always0.5 https://vhio.net/ca/pf/grup-del-programa-de-tumors-genitourinaris-del-snc-i-sarcoma/2022-06-30always0.5 https://vhio.net/ca/pf/grup-de-neoplasies-ginecologiques/2022-06-30always0.5 https://vhio.net/ca/pf/grup-de-genetica-del-cancer-hereditari/2022-06-30always0.5 https://vhio.net/ca/pf/grup-doncology-data-science-odyssey/2022-06-30always0.5 https://vhio.net/ca/pf/grup-doncologia-radioterapica/2022-06-30always0.5 https://vhio.net/ca/pf/grup-de-radiomica/2022-06-30always0.5 https://vhio.net/ca/pf/grup-de-tumors-toracics-i-cancer-de-cap-i-coll/2022-06-30always0.5 https://vhio.net/ca/tecnologies-transversals/2022-06-30always0.5 https://vhio.net/ca/pf/unitat-de-bioinformatica/2022-06-30always0.5 https://vhio.net/ca/pf/grup-de-genomica-del-cancer/2022-06-30always0.5 https://vhio.net/ca/pf/grup-doncologia-molecular/2022-06-30always0.5 https://vhio.net/ca/pf/grup-de-proteomica/2022-06-30always0.5 https://vhio.net/ca/pf/vhioteca-4/2022-06-30always0.5 https://vhio.net/ca/investigadors/2022-06-30always0.5 https://vhio.net/ca/model-de-grups-de-treball/2022-06-30always0.5 https://vhio.net/ca/la-nostra-recerca/2022-06-30always0.5 https://vhio.net/ca/transferencia-de-tecnologia/2022-06-30always0.5 https://vhio.net/ca/oficina-dassaigs-clinics/2022-06-30always0.5 https://vhio.net/ca/cro-academica/2022-06-30always0.5 https://vhio.net/ca/unitat-de-recerca-de-terapia-molecular-del-cancer-uitm-caixaresearch/2022-06-30always0.5 https://vhio.net/ca/programa-de-preseleccio/2022-06-30always0.5 https://vhio.net/ca/infermeres-de-recerca-clinica-oncologica/2022-06-30always0.5 https://vhio.net/ca/unitat-datencio-farmaceutica-en-oncologia/2022-06-30always0.5 https://vhio.net/ca/unitat-de-qualitat-i-processos/2022-06-30always0.5 https://vhio.net/ca/treballar-al-vhio/2022-06-30always0.5 https://vhio.net/ca/oportunitats-de-feina/2022-06-30always0.5 https://vhio.net/ca/desenvolupament-professional/2022-06-30always0.5 https://vhio.net/ca/hrs4r-2/2022-06-30always0.5 https://vhio.net/ca/pla-digualtat/2022-06-30always0.5 https://vhio.net/ca/la-vhio-academy-2/2022-06-30always0.5 https://vhio.net/ca/beques-del-vhio/2022-06-30always0.5 https://vhio.net/ca/aprenentatge-continu/2022-06-30always0.5 https://vhio.net/ca/noticies/2022-06-30always0.5 https://vhio.net/ca/vhio-en-els-mitjans-de-comunicacio/2022-06-30always0.5 https://vhio.net/ca/informacio-corporativa/2022-06-30always0.5 https://vhio.net/ca/esdeveniments/2022-06-30always0.5 https://vhio.net/ca/pacients/2022-06-30always0.5 https://vhio.net/ca/activitats-outreach/2022-06-30always0.5 https://vhio.net/ca/severo-ochoa-3/2022-06-30always0.5 https://vhio.net/ca/2022/06/30/vall-dhebron-tracta-el-primer-pacient-amb-una-terapia-cellular-propia-basada-en-cellules-til-un-tractament-experimental-contra-el-cancer/2022-06-30always0.5 https://vhio.net/ca/2022/06/21/el-dr-josep-tabernero-rep-el-premi-de-recerca-biomedica-2022-de-la-fundacio-lilly/2022-06-30always0.5 https://vhio.net/ca/2022/06/15/astrazeneca-i-vhio-creen-un-programa-per-afavorir-la-recerca-preclinica-i-translacional/2022-06-30always0.5 https://vhio.net/ca/2022/06/10/vall-dhebron-participa-en-un-estudi-per-identificar-un-biomarcador-especific-i-diana-terapeutica-en-cancer-de-mama-her2/2022-06-30always0.5 https://vhio.net/ca/2022/06/09/un-nou-farmac-inhibidor-de-braf-i-permeable-al-cervell-demostra-eficacia-preclinica-per-tractar-amb-mes-eficacia-la-metastasi-cerebral-causada-pel-melanoma/2022-06-30always0.5 https://vhio.net/ca/pf/grup-de-recerca-traslacional-del-cancer-gastrointestinal-no-colorectal/2022-06-30always0.5 https://vhio.net/biosketch-alena-gros/2022-06-30always0.5 https://vhio.net/ca/events__/direna-alonso-i-epigenetic-licensing-of-tumor-promoting-inflammation-in-pancreatic-cancer/2022-06-30always0.5 https://vhio.net/ca/events__/andrew-tutt/2022-06-30always0.5 https://vhio.net/ca/events__/antonio-agudo/2022-06-30always0.5 https://vhio.net/ca/events__/bruno-di-stefano-dissecting-mechanisms-that-govern-cellular-identity/2022-06-30always0.5 https://vhio.net/ca/portal-de-transparencia-2/2022-06-30always0.5 https://vhio.net/ca/avis-legal/2022-06-30always0.5 https://vhio.net/biosketch-josep-tabernero/2022-06-30always0.5 https://vhio.net/biosketch-andres-de-kelety/2022-06-30always0.5 https://vhio.net/biosketch-sergi-cuadrado/2022-06-30always0.5 https://vhio.net/biosketch-alejandro-piris/2022-06-30always0.5 https://vhio.net/biosketch-bianca-pont/2022-06-30always0.5 https://vhio.net/2021/02/23/vhio-led-study-unveils-novel-mechanism-of-resistance-to-t-cell-bispecific-antibodies-and-car-t-targeting-her2-breast-cancer/2022-06-30always0.5 https://vhio.net/2021/07/27/probody-the-promise-of-kinder-antibody-based-immunotherapy/2022-06-30always0.5 https://vhio.net/2021/03/10/spearheading-next-generation-clinical-trials-cancer-core-europes-design-and-development-of-data-rich-dynamic-studies-in-oncology/2022-06-30always0.5 https://vhio.net/2022/06/28/esmo-perspectives-latest-on-target-column-vhios-elena-garralda-on-the-microbiome-and-cancer/2022-06-30always0.5 https://vhio.net/2021/06/15/vhios-elena-garralda-author-of-esmos-perspectives-on-target-column/2022-06-30always0.5 https://vhio.net/2021/12/16/elena-garraldas-latest-esmo-on-target-column-delving-into-dietary-effects-on-tumor-metabolism-progression/2022-06-30always0.5 https://vhio.net/2021/10/05/elena-garraldas-esmo-on-target-column-considering-the-concordance-of-treatment-recommendations-between-central-consensus-mtbs/2022-06-30always0.5 https://vhio.net/2021/03/17/peptomycs-omomyc-based-therapy-put-to-the-clinical-test-first-in-human-phase-iii-trial-approved-to-assess-the-efficacy-and-safety-of-a-novel-myc-inhibitor-2/2022-06-30always0.5 https://vhio.net/2021/01/26/a-new-radiomic-model-based-on-artificial-intelligence-will-help-to-predict-the-response-to-immunotherapy-in-cancer-patients/2022-06-30always0.5 https://vhio.net/2021/02/01/2020-a-record-breaking-year-for-vhios-research-unit-for-molecular-cancer-therapy-uitm-la-caixa-foundation/2022-06-30always0.5 https://vhio.net/2021/01/18/vhio-to-incorporate-guardant-healths-breakthrough-liquid-biopsy-technology-in-2021/2022-06-30always0.5 https://vhio.net/2021/02/26/aacrs-project-genie-hits-another-phenomenal-milestone-9th-public-data-set-now-released/2022-06-30always0.5 https://vhio.net/2021/02/18/proof-of-concept-study-points-to-the-placenta-as-a-protective-barrier-against-covid-19-during-pregnancy/2022-06-30always0.5 https://vhio.net/2021/06/18/all-things-myc-from-the-lab-to-the-clinic-latest-insights-omycs-tips-tricks/2022-06-30always0.5 https://vhio.net/wp-content/uploads/2021/07/Q-CERT-ENAC_2449_LE_2022_rev1.pdf2022-06-30always0.5 https://vhio.net/wp-content/uploads/2021/07/CertificadoER-0376-2013_ES_2019-05-06.pdf2022-06-30always0.5 https://vhio.net/wp-content/uploads/2021/07/Q-Certificat-BPC1701-UITM-VHIO.pdf2022-06-30always0.5 https://vhio.net/wp-content/uploads/2021/07/IQNetES-0376-2013_2019-05-06.pdf2022-06-30always0.5 https://vhio.net/biosketch-joan-seoane/2022-06-30always0.5 https://vhio.net/biosketch-laura-soucek/2022-06-30always0.5 https://vhio.net/wp-content/uploads/2021/10/SR-VHIO-2021.pdf2022-06-30always0.5 https://vhio.net/wp-content/uploads/2021/07/SR-VHIO-2020.pdf2022-06-30always0.5 https://vhio.net/wp-content/uploads/2021/07/SR-VHIO-2019.pdf2022-06-30always0.5 https://vhio.net/wp-content/uploads/2021/07/SR-VHIO-2018.pdf2022-06-30always0.5 https://vhio.net/wp-content/uploads/2021/07/SR-VHIO-2017.pdf2022-06-30always0.5 https://vhio.net/wp-content/uploads/2021/07/SR-VHIO-2016.pdf2022-06-30always0.5 https://vhio.net/wp-content/uploads/2021/07/scientific_report_VHIO_2015.pdf2022-06-30always0.5 https://vhio.net/wp-content/uploads/2021/07/scientific_report_VHIO_2014.pdf2022-06-30always0.5 https://vhio.net/wp-content/uploads/2021/07/scientific_report_VHIO_2013.pdf2022-06-30always0.5 https://vhio.net/wp-content/uploads/2021/07/scientific_report_VHIO_2012.pdf2022-06-30always0.5 https://vhio.net/wp-content/uploads/2021/07/scientific_report_VHIO_2011.pdf2022-06-30always0.5 https://vhio.net/wp-content/uploads/2021/07/scientific_report_VHIO_2010.pdf2022-06-30always0.5 https://vhio.net/wp-content/uploads/2021/07/scientific_report_VHIO_2009.pdf2022-06-30always0.5 https://vhio.net/wp-content/uploads/2021/07/scientific_report_VHIO_2008.pdf2022-06-30always0.5 https://vhio.net/biosketch-tian-tian/2022-06-30always0.5 https://vhio.net/2021/10/06/posttranslational-modification-as-a-regulator-of-protein-function-a-review-of-latest-insights-the-signposting-of-next-directions/2022-06-30always0.5 https://vhio.net/biosketch-violeta-sierra/2022-06-30always0.5 https://vhio.net/2022/02/21/myc-inhibition-halts-metastatic-breast-cancer-progression-by-blocking-tumor-growth-invasion-seeding/2022-06-30always0.5 https://vhio.net/2021/08/26/clinically-qualifying-predictive-biomarkers-of-response-to-parpi-in-patients-with-prostate-cancer/2022-06-30always0.5 https://vhio.net/2021/08/24/counting-down-to-world-cancer-research-day-24-september-lend-your-support-to-this-years-campaign-entitled-cancer-research-works-driving-progress-together/2022-06-30always0.5 https://vhio.net/2021/03/08/immune-cells-in-cerebrospinal-fluid-predictors-of-response-to-immunotherapy-against-brain-metastasis/2022-06-30always0.5 https://vhio.net/biosketch-jonathan-whitfield/2022-06-30always0.5 https://vhio.net/2021/06/23/closing-in-on-myc-inhibition-a-marathon-sprint-finish/2022-06-30always0.5 https://vhio.net/2021/08/25/myc-inhibition-to-more-effectively-thwart-multiple-myeloma-hope-on-the-horizon/2022-06-30always0.5 https://vhio.net/2021/03/16/vhio-study-reveals-myc-wnt-signaling-cross-talk-as-a-culprit-of-myc-driven-tumorigenesis-in-pancreatic-islets/2022-06-30always0.5 https://vhio.net/2021/03/15/newly-appointed-esmo-faculty-vhio-investigators-join-forces-with-other-leading-experts-in-oncology-to-deliver-on-esmos-vision-2025/2022-06-30always0.5 https://vhio.net/biosketch-hector-g-palmer/2022-06-30always0.5 https://vhio.net/biosketch-isabel-puig-borrell/2022-06-30always0.5 https://vhio.net/biosketch-jordi-martinez/2022-06-30always0.5 https://vhio.net/biosketch-josep-villanueva/2022-06-30always0.5 https://vhio.net/biosketch-enriqueta-felip/2022-06-30always0.5 https://vhio.net/2021/10/21/vhio-investigators-co-author-new-esmo-clinical-practice-guideline-with-evidence-based-recommendations-for-the-treatment-of-metastatic-breast-cancer/2022-06-30always0.5 https://vhio.net/biosketch-marta-crespo/2022-06-30always0.5 https://vhio.net/2021/07/12/the-immune-microenvironment-as-a-driver-of-disease-progression-in-chronic-lymphocytic-leukemia/2022-06-30always0.5 https://vhio.net/biosketch-elena-elez/2022-06-30always0.5 https://vhio.net/biosketch-jaume-capdevila/2022-06-30always0.5 https://vhio.net/2021/05/25/the-covid-19-pandemic-widening-the-gender-gap-in-cancer-research/2022-06-30always0.5 https://vhio.net/2021/05/11/vhio-is-participating-prominently-in-a-study-that-seeks-to-evaluate-the-efficacy-of-a-novel-combination-therapy-in-advanced-pancreatic-cancer/2022-06-30always0.5 https://vhio.net/2021/09/27/ivosidenib-as-a-promising-new-contender-against-advanced-cholangiocarcinoma/2022-06-30always0.5 https://vhio.net/2021/02/25/driving-nano-based-approaches-closer-to-the-clinic-vall-dhebron-leads-pilot-study-to-assess-the-efficacy-of-nanoparticles-against-pancreatic-cancer-2/2022-06-30always0.5 https://vhio.net/2021/06/07/asco-oral-phase-iii-cosmic-311-promises-a-new-standard-of-care-for-patients-with-previously-treated-differentiated-thyroid-cancer/2022-06-30always0.5 https://vhio.net/2021/06/14/arranca-un-ensayo-clinico-pionero-para-validar-la-eficacia-de-la-inmunoterapia-en-29-tipos-de-tumores/2022-06-30always0.5 https://vhio.net/2021/01/21/not-to-be-missed-esmos-virtual-and-expert-live-roundtable-on-covid-19-vaccination-in-cancer-patients-this-friday-22-january/2022-06-30always0.5 https://vhio.net/2021/06/22/pegasus-liquid-biopsy-to-personalize-treatment-decision-making-post-surgery/2022-06-30always0.5 https://vhio.net/2021/07/28/the-covid-19-era-the-heightened-risk-of-burnout-in-our-young-oncologists/2022-06-30always0.5 https://vhio.net/2021/01/26/world-cancer-day-2021-saluting-the-strength-of-the-cancer-community-through-the-covid-19-pandemic/2022-06-30always0.5 https://vhio.net/biosketch-joan-carles/2022-06-30always0.5 https://vhio.net/biosketch-rafael-morales/2022-06-30always0.5 https://vhio.net/biosketch-claudia-valverde/2022-06-30always0.5 https://vhio.net/2021/05/04/the-combination-of-immunotherapy-and-targeted-therapies-does-not-improve-outcomes-in-previously-treated-advanced-urothelial-cancer/2022-06-30always0.5 https://vhio.net/2022/01/22/vhio-co-led-studies-illuminate-the-value-of-biomarker-analyses-point-to-a-new-treatment-avenue-for-patients-with-renal-cell-carcinoma/2022-06-30always0.5 https://vhio.net/2021/12/12/under-the-spotlight-nature-reviews-disease-primers-illuminates-the-complexities-of-endometrial-cancer-updates-on-recent-advancements-emerging-trends-and-therapeutic-opportunities/2022-06-30always0.5 https://vhio.net/2022/06/27/esmo-clinical-practice-guideline-consensus-recommendations-next-directions-in-the-treatment-and-follow-up-of-endometrial-cancer/2022-06-30always0.5 https://vhio.net/2021/05/12/cemiplimab-steps-up-as-the-first-immune-based-therapy-to-improve-overall-survival-in-patients-with-recurrent-andor-metastatic-cervical-cancer/2022-06-30always0.5 https://vhio.net/biosketch-judith-balmana/2022-06-30always0.5 https://vhio.net/2021/08/02/a-hand-pick-of-latest-vhio-research-highlights-aimed-at-the-more-precise-diagnosis-of-familial-breast-and-ovarian-cancer/2022-06-30always0.5 https://vhio.net/2021/06/03/asco-plenary-parpi-prevents-disease-recurrence-in-brca-mutated-high-risk-early-stage-breast-cancer/2022-06-30always0.5 https://vhio.net/biosketch-rodrigo-dientsmann/2022-06-30always0.5 https://vhio.net/biosketch-jordi-giralt/2022-06-30always0.5 https://vhio.net/biosketch-kinga-bernatowicz/2022-06-30always0.5 https://vhio.net/biosketch-francesco-grussu/2022-06-30always0.5 https://vhio.net/biosketch-alonso-garcia-ruiz/2022-06-30always0.5 https://vhio.net/biosketch-marta-ligero/2022-06-30always0.5 https://vhio.net/biosketch-olivia-prior-palomares/2022-06-30always0.5 https://vhio.net/biosketch-camilo-monreal/2022-06-30always0.5 https://vhio.net/biosketch-carlos-macarro/2022-06-30always0.5 https://vhio.net/biosketch-iker-zubieta/2022-06-30always0.5 https://vhio.net/biosketch-maria-balaguer/2022-06-30always0.5 https://vhio.net/biosketch-andreu-antolin/2022-06-30always0.5 https://vhio.net/2021/02/12/expert-panel-discussion-latest-treatment-regimens-novel-therapies-and-advances-against-nsclc/2022-06-30always0.5 https://vhio.net/2021/06/07/asco-oral-landmark-study-rings-in-the-first-immune-based-therapy-for-patients-with-resected-high-risk-early-stage-non-small-cell-lung-cancer/2022-06-30always0.5 https://vhio.net/2021/10/22/vhios-enriqueta-felip-takes-up-the-reins-as-seom-president-2021-2023/2022-06-30always0.5 https://vhio.net/2020/12/31/seeking-out-predictive-biomarkers-for-a-longer-term-response-to-immunotherapy-against-nsclc/2022-06-30always0.5 https://vhio.net/2021/09/22/vhio-at-esmo-2021-the-promise-of-potential-new-therapeutic-avenues-against-nsclc/2022-06-30always0.5 https://vhio.net/2021/09/27/ecancer-catches-up-with-vhios-enriqueta-felip-cristina-saura-on-new-therapeutic-avenues-against-nsclc-and-breast-cancer-respectively/2022-06-30always0.5 https://vhio.net/biosketch-ana-vivancos/2022-06-30always0.5 https://vhio.net/2021/06/10/vhio-joins-a-unit-of-biomedical-proteomics-led-by-irb-barcelona-towards-personalized-medicine/2022-06-30always0.5 https://vhio.net/biosketch-maria-abad/2022-06-30always0.5 https://vhio.net/biosketch-francesc-canals/2022-06-30always0.5 https://vhio.net/biosketch-joaquin-mateo/2022-06-30always0.5 https://vhio.net/biosketch-lara-nonell/2022-06-30always0.5 https://vhio.net/biosketch-paolo-g-nuciforo/2022-06-30always0.5 https://vhio.net/biosketch-ana-oaknin/2022-06-30always0.5 https://vhio.net/biosketch-jose-antonio-seoane/2022-06-30always0.5 https://vhio.net/biosketch-cesar-serrano/2022-06-30always0.5 https://vhio.net/biosketch-meritxell-bellet/2022-06-30always0.5 https://vhio.net/biosketch-orland-diez/2022-06-30always0.5 https://vhio.net/biosketch-sara-gutierrez/2022-06-30always0.5 https://vhio.net/biosketch-nicolas-herranz/2022-06-30always0.5 https://vhio.net/biosketch-eva-munoz/2022-06-30always0.5 https://vhio.net/biosketch-mafalda-oliveira/2022-06-30always0.5 https://vhio.net/biosketch-cristina-suarez/2022-06-30always0.5 https://vhio.net/biosketch-marta-beltran/2022-06-30always0.5 https://vhio.net/biosketch-susana-munoz/2022-06-30always0.5 https://vhio.net/biosketch-angeles-penuelas/2022-06-30always0.5 https://vhio.net/biosketch-isabel-cidoncha/2022-06-30always0.5 https://vhio.net/biosketch-maria-queralt-gorgas/2022-06-30always0.5 https://vhio.net/biosketch-gemma-sala/2022-06-30always0.5 https://vhio.net/2022/06/20/ref-35-2022-so-academic-officer/2022-06-30always0.5 https://vhio.net/2022/05/31/ref-28-2022-bioinformatician/2022-06-30always0.5 https://vhio.net/2022/05/30/ref-34-2022-phd-student-diffusion-mri-and-artificial-intelligence-in-oncology/2022-06-30always0.5 https://vhio.net/2022/05/26/ref-32-2022-so-tecnico-de-apoyo-a-la-investigacion-clinica/2022-06-30always0.5 https://vhio.net/2022/05/24/ref-31-2022-laboratory-technician/2022-06-30always0.5 https://vhio.net/2022/05/13/ref-29-2022-administrativoa-uitm-unidad-de-investigacion-de-terapia-molecular-del-cancer/2022-06-30always0.5 https://vhio.net/2022/05/13/ref-6_2022-clinical-project-manager-2/2022-06-30always0.5 https://vhio.net/2022/05/13/ref-30-2022-postdoctoral-position-in-breast-cancer-translational-research/2022-06-30always0.5 https://vhio.net/2022/05/06/ref-27-2022-enfermeroa-de-ensayos-clinicos/2022-06-30always0.5 https://vhio.net/2022/05/05/ref-26-2022-post-doctoral-research/2022-06-30always0.5 https://vhio.net/2022/05/03/ref-25-2022-sample-manager/2022-06-30always0.5 https://vhio.net/2022/04/28/ref-24-2022-gestora-de-dades-dassaigs-clinics/2022-06-30always0.5 https://vhio.net/2022/04/08/ref-23-2022-tecnicoa-de-investigacion-clinica/2022-06-30always0.5 https://vhio.net/2022/04/07/ref-22-2022-clinical-trials-quality-manager/2022-06-30always0.5 https://vhio.net/2022/04/01/ref-21-2022-sample-manager/2022-06-30always0.5 https://vhio.net/2022/03/28/ref-20-2022-graduates-training-officer/2022-06-30always0.5 https://vhio.net/2022/03/16/ref-19-2022-auxiliar-de-laboratorio/2022-06-30always0.5 https://vhio.net/2022/03/07/ref-18-2022-phd-student-in-machine-learning-for-medical-image-analysis-and-multimodal-data-integration-to-join-the-radiomics-group/2022-06-30always0.5 https://vhio.net/2022/03/07/ref-17-2022-bioestadisticoa-en-onco-hematologia/2022-06-30always0.5 https://vhio.net/2022/03/03/ref-16-2022-gestora-de-datos-clinicos-y-moleculares-grupo-de-oncology-data-science/2022-06-30always0.5 https://vhio.net/2022/02/28/ref-14-2022-phd-student/2022-06-30always0.5 https://vhio.net/2022/02/28/ref-13-2022-laboratory-technician-specialized-in-research-with-animal-models/2022-06-30always0.5 https://vhio.net/2022/02/22/ref-45-2021-administrativo-de-ensayos-clinicos-clinical-trial-assistant/2022-06-30always0.5 https://vhio.net/2022/02/18/ref-12-2022-research-technician-ngs/2022-06-30always0.5 https://vhio.net/2022/02/18/ref-10-2022-research-technician/2022-06-30always0.5 https://vhio.net/2022/02/18/ref-09-2022-postdoctoral-position/2022-06-30always0.5 https://vhio.net/2022/02/16/ref-11-2022-coordinadordata-manager/2022-06-30always0.5 https://vhio.net/2022/01/20/ref-8-2022-in-house-legal-advisor/2022-06-30always0.5 https://vhio.net/2022/01/19/ref-6_2022-clinical-project-manager/2022-06-30always0.5 https://vhio.net/2022/01/13/ref-1_2022-medico-facultativo-con-dedicacion-a-pacientes-con-sarcomas/2022-06-30always0.5 https://vhio.net/2022/01/13/ref-53-2021-postdoctoral-researcher-at-the-experimental-hematology-group/2022-06-30always0.5 https://vhio.net/2022/01/11/ref-5_2022_so-early-researchers-academic-programmes-officer/2022-06-30always0.5 https://vhio.net/2022/01/05/ref-2-2022-postdoctoral-researcher-in-computational-biology/2022-06-30always0.5 https://vhio.net/2022/01/04/ref-44-2021-postdoctoral-researcher-in-computational-biology/2022-06-30always0.5 https://vhio.net/2021/12/27/ref-45-2021-clinical-trial-assistant/2022-06-30always0.5 https://vhio.net/2021/12/17/ref-51-2021-farmaceuticoa/2022-06-30always0.5 https://vhio.net/2021/12/17/ref-55-2021-junior-postdoctoral-researcher/2022-06-30always0.5 https://vhio.net/2021/12/10/ref-54-2021-tecnicoa-administrativoa-compras/2022-06-30always0.5 https://vhio.net/2021/12/02/ref-52-2021-auxiliar-administrativoa/2022-06-30always0.5 https://vhio.net/2021/11/23/ref-50-2021-medical-image-processing-physicistengineer/2022-06-30always0.5 https://vhio.net/2021/11/23/ref-49-2021-research-physicistengineer/2022-06-30always0.5 https://vhio.net/2021/11/12/ref-48-2021-monitor-de-ensayos-clinicos-cra/2022-06-30always0.5 https://vhio.net/2021/11/11/ref-47-2021-auxiliar-depoteca/2022-06-30always0.5 https://vhio.net/2021/11/10/ref-46-2021-bioinformatician/2022-06-30always0.5 https://vhio.net/2021/11/08/ref-42-2021-gestora-de-aplicativo-ensayos-clinicos/2022-06-30always0.5 https://vhio.net/2021/11/04/ref-39-2021-farmaceuticoa-senior-unidad-farmacia-de-ensayos-clinicos-en-onco-hematologia/2022-06-30always0.5 https://vhio.net/2021/11/02/ref-37-2021-bioinformatician/2022-06-30always0.5 https://vhio.net/2021/10/22/ref-43-2021-phd-student-in-magnetic-resonance-imaging/2022-06-30always0.5 https://vhio.net/2021/10/18/ref-41-2021-animal-laboratory-technician/2022-06-30always0.5 https://vhio.net/2021/09/29/ref-40-2021-specialized-laboratory-technician-at-cancer-genomics-laboratory/2022-06-30always0.5 https://vhio.net/2021/09/08/ref-38-2021-young-researchers-programmes-officer/2022-06-30always0.5 https://vhio.net/2021/08/24/ref-36-2021-laboratory-technician/2022-06-30always0.5 https://vhio.net/2021/08/23/ref-35-2021-monitor-de-ensayos-clinicos-cra/2022-06-30always0.5 https://vhio.net/2021/08/05/ref-34-2021-tecnica-de-gestio-de-projectes-i-assaigs-clinics/2022-06-30always0.5 https://vhio.net/2021/07/21/ref-33-2021-tecnicoa-de-apoyo-administrativo-a-la-investigacion/2022-06-30always0.5 https://vhio.net/2021/07/07/ref-32-2021-lead-study-coordinator/2022-06-30always0.5 https://vhio.net/2021/07/05/ref-31-2021-enfermeroa-ensayos-clinicos/2022-06-30always0.5 https://vhio.net/2021/06/21/ref-29-2021-tecnica-de-laboratori-pel-grup-dhematologia-experimental/2022-06-30always0.5 https://vhio.net/2021/06/17/ref-25-2021-cra-seniorlead-cra/2022-06-30always0.5 https://vhio.net/2021/06/17/ref-30-2021-farmaceuticoa-unidad-farmacia-ensayos-clinicos-onco-hematologia/2022-06-30always0.5 https://vhio.net/2021/05/27/ref-28-2021-gestora-de-datos-clinicos-y-moleculares/2022-06-30always0.5 https://vhio.net/2021/05/26/ref-27-2021-laboratory-technician/2022-06-30always0.5 https://vhio.net/2021/05/19/ref-26-2021-tecnicoa-de-farmacia-refuerzo-periodo-vacacional/2022-06-30always0.5 https://vhio.net/2021/04/23/ref-24-2021-responsable-de-la-oficina-academica-de-vhio/2022-06-30always0.5 https://vhio.net/2021/04/23/ref-23-2021-monitora-de-ensayos-clinicos-cra/2022-06-30always0.5 https://vhio.net/2021/04/22/ref-22-2021-tecnicoa-de-laboratorio-de-anatomia-patologica/2022-06-30always0.5 https://vhio.net/2021/04/22/ref-28-2020-monitora-de-ensayos-clinicos-cra-2/2022-06-30always0.5 https://vhio.net/2021/04/20/ref-21-2021-gestora-de-dades-dassaigs-clinics/2022-06-30always0.5 https://vhio.net/2021/04/06/ref-20-2021-enfermeroa-de-investigacion/2022-06-30always0.5 https://vhio.net/2021/03/12/ref-19-2021-enfermeroa-de-investigacion/2022-06-30always0.5 https://vhio.net/2021/03/12/ref-17-2021-postdoctoral-researcher-in-computational-biology/2022-06-30always0.5 https://vhio.net/2021/03/11/ref-13-2021-laboratory-technician-in-stem-cells-and-cancer-group/2022-06-30always0.5 https://vhio.net/2021/03/11/ref-18-2021-fellowship-in-gastrointestinal-endocrine-tumors-group/2022-06-30always0.5 https://vhio.net/2021/03/10/ref-16-2021-post-doctoral-research-fellow/2022-06-30always0.5 https://vhio.net/2021/03/04/ref-14-2021-coordinadora-assaigs-clinics/2022-06-30always0.5 https://vhio.net/2021/03/01/ref-15-2021-computer-scientist/2022-06-30always0.5 https://vhio.net/2021/02/22/ref-03-2021-enfermeroa-de-ensayos-clinicos/2022-06-30always0.5 https://vhio.net/2021/02/18/ref-10-2021-laboratory-technician-position-at-growth-factors-lab/2022-06-30always0.5 https://vhio.net/2021/02/18/ref-12-2021-farmaceuticoa-unidad-farmacia-de-ensayos-clinicos-en-onco-hematologia/2022-06-30always0.5 https://vhio.net/2021/02/03/ref-06-2021-postdoctoral-researcher-in-breast-cancer-translational-research/2022-06-30always0.5 https://vhio.net/2021/02/03/ref-07-2021-tecnica-de-gestio-de-projectes/2022-06-30always0.5 https://vhio.net/2021/01/29/ref-09-2021-gestora-de-datos-clinicos-y-moleculares-para-incorporarse-dentro-del-grupo-de-oncology-data-science/2022-06-30always0.5 https://vhio.net/2021/01/28/ref-08-2021-pathologist-in-breast-and-prostate-cancer-translational-research/2022-06-30always0.5 https://vhio.net/2021/01/21/ref-04-2021-research-technician/2022-06-30always0.5 https://vhio.net/2021/01/04/ref-01-2021-prostate-bioinformatics/2022-06-30always0.5 https://vhio.net/2020/12/22/ref-29-2020-lawyer-clinical-and-data-protection/2022-06-30always0.5 https://vhio.net/2020/12/18/ref-27-2020-laboratory-technician/2022-06-30always0.5 https://vhio.net/2020/12/03/ref-26-2020-specialized-laboratory-technician-at-cancer-genomics-laboratory/2022-06-30always0.5 https://vhio.net/2020/11/24/ref-25-2020-tecnicoa-de-farmacia-unidad-de-farmacia-de-ensayos-clinicos-en-onco-hematologia/2022-06-30always0.5 https://vhio.net/2020/11/20/ref-062020-coordinadora-data-manager/2022-06-30always0.5 https://vhio.net/2020/11/03/ref-23-2020-postdoctoral-researcher-to-join-its-hereditary-cancer-genetics-group/2022-06-30always0.5 https://vhio.net/2020/11/03/ref-24-2020-monitora-de-ensayos-clinicos-cra/2022-06-30always0.5 https://vhio.net/2020/10/09/ref-22-2020-enfermeroa-de-investigacion/2022-06-30always0.5 https://vhio.net/2020/10/09/ref-21-2020-sample-manager/2022-06-30always0.5 https://vhio.net/2020/10/06/ref-18-2020-tecnico-en-gestion-de-contratos-fm/2022-06-30always0.5 https://vhio.net/2020/10/05/ref-20-2020-laboratory-technicianlaboratory-manager/2022-06-30always0.5 https://vhio.net/2020/09/30/ref-14-2020-bioinformatician/2022-06-30always0.5 https://vhio.net/2020/09/23/ref-16-2020-phd-prostate-cancer-translational-research-group/2022-06-30always0.5 https://vhio.net/2020/09/16/ref-15-2020-laboratory-technician-tumor-biomarkers-group/2022-06-30always0.5 https://vhio.net/2020/06/29/ref-13-2020-bioinformatician/2022-06-30always0.5 https://vhio.net/2020/06/19/ref-12-2020-assistant/2022-06-30always0.5 https://vhio.net/2020/06/18/ref-11-2020-farmaceuticoa-unidad-farmacia-de-ensayos-clinicos-en-onco-hematologia/2022-06-30always0.5 https://vhio.net/2020/06/17/ref-10-2020-auxiliar-laboratorio/2022-06-30always0.5 https://vhio.net/2020/05/29/ref-092020-tecnicoa-de-farmacia-unidad-de-farmacia-de-ensayos-clinicos-en-onco-hematologia/2022-06-30always0.5 https://vhio.net/2020/05/29/ref-082020-farmaceuticoa-unidad-de-farmacia-de-ensayos-clinicos-en-onco-hematologia/2022-06-30always0.5 https://vhio.net/2020/03/16/ref-072020-specialized-laboratory-technician-at-cancer-genomics-laboratory/2022-06-30always0.5 https://vhio.net/2020/03/16/ref-052020-clinical-project-manager/2022-06-30always0.5 https://vhio.net/2020/03/05/ref-32020-phd-student-position-at-growth-factors-laboratory/2022-06-30always0.5 https://vhio.net/2020/03/05/ref-42020-post-doctoral-position-al-growth-factors-laboratory/2022-06-30always0.5 https://vhio.net/2020/02/13/ref-12020-laboratory-research-technician/2022-06-30always0.5 https://vhio.net/2020/02/03/ref-172019-medical-image-processing-physicistengineer/2022-06-30always0.5 https://vhio.net/2020/01/08/ref-36-2019-coordinator-bioinformatics-support-unit/2022-06-30always0.5 https://vhio.net/2020/01/03/ref-022019-laboratory-technician-tumor-immunology-and-immunotherapy-group/2022-06-30always0.5 https://vhio.net/2020/01/03/ref-012020-laboratory-technician/2022-06-30always0.5 https://vhio.net/2019/12/12/ref-342019-laboratory-technician/2022-06-30always0.5 https://vhio.net/2019/12/02/ref-332019-fellowship-in-breast-cancer-unit/2022-06-30always0.5 https://vhio.net/2019/11/20/ref-322019-bioinformatician/2022-06-30always0.5 https://vhio.net/2019/11/20/ref-312019-laboratory-research-technician/2022-06-30always0.5 https://vhio.net/2019/11/05/ref-30-2019-postdoctoral-researcher/2022-06-30always0.5 https://vhio.net/2019/11/05/ref-29-2019-coordinadora-laboratoris/2022-06-30always0.5 https://vhio.net/2019/10/22/ref-282019-tecnicoa-facturacion/2022-06-30always0.5 https://vhio.net/2019/10/15/ref-27-2019-tecnica-laboratori/2022-06-30always0.5 https://vhio.net/2019/10/07/ref-032019-tecincoa-en-relaciones-laborales-rrhh/2022-06-30always0.5 https://vhio.net/2019/09/26/ref-25-2019-clinical-investigator-early-drug-development/2022-06-30always0.5 https://vhio.net/2019/09/16/ref-242019-phd-sarcoma-translational-research-group/2022-06-30always0.5 https://vhio.net/2019/09/04/ref-232019-administratiuva-uitm/2022-06-30always0.5 https://vhio.net/2019/08/08/ref-222019-infermera-de-investigacio/2022-06-30always0.5 https://vhio.net/2019/08/07/ref-152019-post-doctoral-investigator/2022-06-30always0.5 https://vhio.net/2019/07/08/ref-202019-coordinadora-datos-dassaigs-clinic/2022-06-30always0.5 https://vhio.net/2019/05/27/ref-162019-laboratory-technician/2022-06-30always0.5 https://vhio.net/2019/05/21/ref-1419-coordinadordata-manager-dassaigs-clinics-en-oncologia/2022-06-30always0.5 https://vhio.net/2019/05/17/phd-student-experimental-hematology-group/2022-06-30always0.5 https://vhio.net/2019/04/29/ref-122019-sample-manager/2022-06-30always0.5 https://vhio.net/2019/04/18/ref-052019-digital-pathology-scientist/2022-06-30always0.5 https://vhio.net/2019/04/09/ref-112019-tecnica-de-laboratori-grup-dhematologia-experimental/2022-06-30always0.5 https://vhio.net/2019/04/08/ref-232018-fellowship-position-early-clinical-drug-development/2022-06-30always0.5 https://vhio.net/2019/03/26/ref-102019-monitora-de-ensayos-clinicos-fase-iiiiiiiv/2022-06-30always0.5 https://vhio.net/2019/03/21/ref-092019-enfermeroa-de-ensayos-clinicos/2022-06-30always0.5 https://vhio.net/2019/03/20/ref-082019-laboratory-technician-tumor-immunology-and-immunotherapy-group/2022-06-30always0.5 https://vhio.net/2019/03/07/ref-072019-administrativoa-para-incorporarse-en-la-uitm-unidad-de-investigacion-de-terapia-molecular-del-cancer/2022-06-30always0.5 https://vhio.net/2019/03/06/ref-062019-postdoctoral-fellow-tumor-immunology-immunotherapy-group/2022-06-30always0.5 https://vhio.net/2019/02/26/ref-242018-fellowship-in-breast-cancer-unit/2022-06-30always0.5 https://vhio.net/2019/02/07/ref-042019-tecnicoa-de-gestion-de-proyectos/2022-06-30always0.5 https://vhio.net/2019/01/24/ref-172018-postdoctoral-position/2022-06-30always0.5 https://vhio.net/2019/01/17/ref-022019-gestora-de-datos-clinicos-y-moleculares-grupo-de-ciencia-de-datos-en-oncologia/2022-06-30always0.5 https://vhio.net/2019/01/14/ref-012019-post-doctoral-scientist-applied-genetics-of-metastatic-cancer-group/2022-06-30always0.5 https://vhio.net/2018/12/01/ref-142018-senior-junior-bioinformatician/2022-06-30always0.5 https://vhio.net/2018/11/30/ref-0718-coordinadordata-manager-de-ensayos-clinicos-en-oncologia/2022-06-30always0.5 https://vhio.net/2018/11/30/fellowship-in-gastrointestinal-unit/2022-06-30always0.5 https://vhio.net/2018/11/29/ref-202018-research-scientist-in-thoracic-cancer-genomics/2022-06-30always0.5 https://vhio.net/2018/11/28/gestor-de-datos-clinicos-y-moleculares-en-oncologia-para-incorporarse-en-el-grupo-de-early-drug-development/2022-06-30always0.5 https://vhio.net/2018/09/19/ref-252018-postdoctoral-researcher-in-prostate-cancer-dna-damage-repair-translational-research/2022-06-30always0.5 https://vhio.net/2018/07/27/ref-262018-medical-image-processing-physicistengineer-radiomics-group/2022-06-30always0.5 https://vhio.net/2018/07/26/ref-222018-secretaria-departament-dhematologia/2022-06-30always0.5 https://vhio.net/2018/07/26/ref-122018-research-assistant-in-prostate-and-breast-cancer-translational-research/2022-06-30always0.5 https://vhio.net/2018/07/25/ref-16-2018-responsable-de-lequip-de-coordinacio-i-gestio-de-dades-destudis-en-hematologia/2022-06-30always0.5 https://vhio.net/2018/07/01/ref-212018-project-manager-for-our-scientific-coordination-area/2022-06-30always0.5 https://vhio.net/2018/05/08/ref-0918-enfermeroa-ensayos-clinicos/2022-06-30always0.5 https://vhio.net/2018/05/07/ref-152018-clinical-trial-assistant/2022-06-30always0.5 https://vhio.net/2018/05/07/ref-132018-position-in-genomics-research-laboratory-technician/2022-06-30always0.5 https://vhio.net/2018/05/01/ref-04-2018-pathologist-position/2022-06-30always0.5 https://vhio.net/2018/04/30/ref-1018-tecnicoa-de-laboratorio-de-anatomia-patologica/2022-06-30always0.5 https://vhio.net/2018/04/27/ref-112018-assistant/2022-06-30always0.5 https://vhio.net/2018/03/10/postdoctoral-researcher-to-join-its-tumor-biomarkers-group/2022-06-30always0.5 https://vhio.net/2018/03/09/ref-0818-monitora-de-ensayos-clinicos-fase-iiiiiiiv/2022-06-30always0.5 https://vhio.net/2018/02/06/ref-0618-research-laboratory-technician/2022-06-30always0.5 https://vhio.net/2018/01/31/ref-05-2018-quality-clinical-trials-technician/2022-06-30always0.5 https://vhio.net/2018/01/17/ref-0318-secretaria/2022-06-30always0.5 https://vhio.net/2018/01/11/ref-0218-enfermeroa-de-investigacion/2022-06-30always0.5 https://vhio.net/2018/01/03/ref-22-tecnicoa-de-facturacion-y-contabilidad/2022-06-30always0.5 https://vhio.net/2017/12/28/research-financial-post-award-officer-tecnic-de-gestio-de-projectes/2022-06-30always0.5 https://vhio.net/2017/11/16/the-vall-dhebron-institute-of-oncology-vhio-seeks-a-laboratory-technician-to-join-its-prostate-cancer-translational-research-group/2022-06-30always0.5 https://vhio.net/2017/11/16/the-vall-dhebron-institute-of-oncology-vhio-seeks-a-post-doctoral-investigator-to-join-the-prostate-cancer-translational-research-group/2022-06-30always0.5 https://vhio.net/2017/11/16/the-vall-dhebron-institute-of-oncology-vhio-seeks-an-mr-research-physicistengineer-to-join-the-radiomics-group-2/2022-06-30always0.5 https://vhio.net/2017/11/14/tecnico-de-apoyo-al-laboratorio-de-genomica-y-al-programa-de-prescreening-molecular/2022-06-30always0.5 https://vhio.net/2017/11/14/auxiliar-de-farmacia/2022-06-30always0.5 https://vhio.net/2017/11/06/15122017-tecnica-compres/2022-06-30always0.5 https://vhio.net/2017/10/19/fellowship-in-early-drug-development-3/2022-06-30always0.5 https://vhio.net/2017/10/18/research-laboratory-technician-6/2022-06-30always0.5 https://vhio.net/2017/10/10/research-laboratory-technician-5/2022-06-30always0.5 https://vhio.net/2017/09/12/monitora-de-ensayos-clinicos-fase-iiiiiiiv-process-closed-2/2022-06-30always0.5 https://vhio.net/2017/07/18/responsable-de-lequip-de-coordinacio-i-gestio-de-dades-destudis-en-fase-i-process-closed-3/2022-06-30always0.5 https://vhio.net/2017/07/18/quality-assurance-technician-3/2022-06-30always0.5 https://vhio.net/2017/07/05/research-laboratory-technician-in-cancer-genomics-maternity-leave-cover-temporary-contract-process-closed-3/2022-06-30always0.5 https://vhio.net/2017/05/05/coordinadora-de-laboratoris-3/2022-06-30always0.5 https://vhio.net/2017/04/13/gestora-de-datos-clinicos-y-moleculares-en-oncologia-tumores-gastrointestinales-process-closed-2/2022-06-30always0.5 https://vhio.net/2017/04/12/tecnicoa-de-laboratorio-con-categoria-b-en-experimentacion-con-animales-process-closed-2/2022-06-30always0.5 https://vhio.net/2017/03/27/tecnica-compres-process-closed-2/2022-06-30always0.5 https://vhio.net/2017/03/21/post-doctoral-position-process-closed-2/2022-06-30always0.5 https://vhio.net/2017/03/15/enfermeroa-ensayos-clinicos-process-closed-2/2022-06-30always0.5 https://vhio.net/2017/01/01/coordinadordata-manager-de-ensayos-clinicos-en-oncologia-2/2022-06-30always0.5 https://vhio.net/2016/12/31/pathologist-position-process-closed/2022-06-30always0.5 https://vhio.net/2016/11/16/tecnicoa-de-laboratorio-de-anatomia-patologica-process-closed-3/2022-06-30always0.5 https://vhio.net/2016/11/02/postdoctoral-position-at-the-experimental-hematology-group-process-closed-3/2022-06-30always0.5 https://vhio.net/2016/11/02/project-manager-prescreening-program-process-closed-2/2022-06-30always0.5 https://vhio.net/2016/11/02/tecnicoa-de-facturacion-process-closed-2/2022-06-30always0.5 https://vhio.net/2016/10/26/phd-student-to-join-its-tumor-immunology-and-immunotherapy-group-process-closed-2/2022-06-30always0.5 https://vhio.net/2016/10/26/postdoctoral-fellow-to-join-its-tumor-immunology-and-immunotherapy-group-process-closed-2/2022-06-30always0.5 https://vhio.net/2016/10/06/sample-manager-process-closed-2/2022-06-30always0.5 https://vhio.net/2016/10/04/gestora-de-dades-dassaigs-clinics-en-oncologia-process-closed-2/2022-06-30always0.5 https://vhio.net/2016/06/22/phd-student-process-closed-2/2022-06-30always0.5 https://vhio.net/2016/06/22/laboratory-technician-to-join-its-tumor-immunology-and-immunotherapy-group-process-closed-2/2022-06-30always0.5 https://vhio.net/2016/05/18/research-financial-post-award-officer-process-closed-2/2022-06-30always0.5 https://vhio.net/2015/12/10/oustanding-principal-investigators-in-basictranslational-cancer-research-immunology-process-closed-2/2022-06-30always0.5 https://vhio.net/2015/12/04/pre-doctoral-position-process-closed/2022-06-30always0.5 https://vhio.net/2015/11/24/immediate-call-vhio-seeks-outstanding-and-highly-driven-postdoctoral-scientists-in-breast-cancer-biology-oncoimmunology-process-closed/2022-06-30always0.5 https://vhio.net/2015/10/23/auxiliar-de-coordinacio-process-closed/2022-06-30always0.5 https://vhio.net/2015/09/22/postdoctoral-position-process-closed/2022-06-30always0.5 https://vhio.net/wp-content/uploads/2022/01/01-VHIO-Gap-Analysis_v250717.pdf2022-06-30always0.5 https://vhio.net/wp-content/uploads/2022/01/02-VHIO-Action-Plan_v270717.pdf2022-06-30always0.5 https://vhio.net/wp-content/uploads/2022/01/03-VHIO-Extended-Action-Plan_v270717.pdf2022-06-30always0.5 https://vhio.net/wp-content/uploads/2021/07/Plan-Igualdad-VHIO-Diagnostico_v2.pdf2022-06-30always0.5 https://vhio.net/biosketch-imma-falero/2022-06-30always0.5 https://vhio.net/2022/06/22/vhio-at-esmo-world-gi-who-what-and-when/2022-06-30always0.5 https://vhio.net/2022/06/17/win-symposium-2022-coming-to-barcelona-29-30-october/2022-06-30always0.5 https://vhio.net/2022/06/07/on-the-ground-at-asco-two-vhio-led-studies-show-the-promise-of-immunotherapy-for-the-treatment-of-advanced-endometrial-and-cervical-cancer/2022-06-30always0.5 https://vhio.net/2022/06/07/vhio-at-asco-2022-reporting-advances-in-drug-discovery-and-development/2022-06-30always0.5 https://vhio.net/2022/06/06/vhio-at-asco-vigex-predictive-biomarker-to-immune-checkpoint-inhibitor-pembrolizumab-in-patients-with-advanced-disease/2022-06-30always0.5 https://vhio.net/2022/06/06/2022-asco-annual-meeting-the-promise-of-novel-antibody-drug-conjugate-sacituzumab-govitecan-and-the-policing-of-advancedmetastatic-breast-cancer-by-liquid-biopsy/2022-06-30always0.5 https://vhio.net/2020/11/09/diario-medico-la-inmunoterapia-se-asienta-en-un-subtipo-de-cancer-de-endometrio-avanzado-2/2022-06-30always0.5 https://vhio.net/2020/11/09/la-vanguardia-josep-tabernero-y-silvia-osuna-reciben-el-premi-nacional-de-recerca-2/2022-06-30always0.5 https://vhio.net/2019/11/20/abc-la-desconocida-importancia-de-los-ensayos-clinicos-2/2022-06-30always0.5 https://vhio.net/2019/10/04/la-vanguardia-nuevos-farmacos-abren-una-nueva-era-contra-el-cancer-de-ovario-2/2022-06-30always0.5 https://vhio.net/2019/07/16/royalcentral-queen-letizia-attends-international-cancer-research-summit-grand-challenge-in-madrid-2/2022-06-30always0.5 https://vhio.net/2018/12/31/httpselpais-comccaa20181229catalunya1546101666_979253-html/2022-06-30always0.5 https://vhio.net/2018/10/04/el-periodico-vall-dhebron-desarrolla-un-farmaco-capaz-de-centrarse-en-un-tipo-de-cancer-de-mama-2/2022-06-30always0.5 https://vhio.net/2018/10/01/eitb-radio-el-40-de-los-tumores-se-puede-prevenir-con-habitos-de-vida-saludables/2022-06-30always0.5 https://vhio.net/2018/08/07/la-razon-con-maria-abad-hemos-conseguido-una-tecnica-alternativa-a-la-modificacion-genetica/2022-06-30always0.5 https://vhio.net/2016/03/05/pau-dones-las-buenas-canciones-salen-de-los-buenos-motivos/2022-06-30always0.5 https://vhio.net/wp-content/uploads/2021/10/VHIO-Presentacion-institucional.pdf2022-06-30always0.5 https://vhio.net/events__/como-llevar-una-alimentacion-mas-consciente-y-disfrutar-de-la-comida-saludable-2/2022-06-30always0.5 https://vhio.net/events__/oskar-marin-drug-resistance-mechanisms-and-cancer-cell-vulnerabilities-2/2022-06-30always0.5 https://vhio.net/events__/carlos-arteaga-bench-to-bedside-approaches-to-discover-mechanisms-of-resistance-to-endocrine-therapy-in-breast-cancer-2/2022-06-30always0.5 https://vhio.net/events__/lara-nonell-pau-torres-merce-chavarria-vhioinformatics-your-bioinformatics-facility/2022-06-30always0.5 https://vhio.net/category/en_news/2022-06-30always0.5 https://vhio.net/tag/asconivolumab/2022-06-30always0.5 https://vhio.net/tag/checkmate-9er/2022-06-30always0.5 https://vhio.net/tag/cristina-suarez/2022-06-30always0.5 https://vhio.net/tag/renal-cancer/2022-06-30always0.5 https://vhio.net/tag/renal-cell-cancer/2022-06-30always0.5 https://vhio.net/category/featured-news-home/2022-06-30always0.5 https://vhio.net/category/featured-news/2022-06-30always0.5 https://vhio.net/tag/astrazeneca-en/2022-06-30always0.5 https://vhio.net/tag/dr-tabernero-en/2022-06-30always0.5 https://vhio.net/tag/josep-tabernero/2022-06-30always0.5 https://vhio.net/tag/partner-of-choice-program/2022-06-30always0.5 https://vhio.net/tag/preclinical-research/2022-06-30always0.5 https://vhio.net/tag/translational-research/2022-06-30always0.5 https://vhio.net/2021/12/09/a-seal-of-scientific-leadership-at-global-level-vhio-accredited-as-a-severo-ochoa-centre-of-excellence/2022-06-30always0.5 https://vhio.net/2022/01/11/novel-microprotein-unmasked-as-a-regulator-of-neural-differentiation-neurite-formation-via-calcium-dynamics/2022-06-30always0.5 https://vhio.net/es/biosketch-francesc-bosch-2/2022-06-30always0.5 https://vhio.net/ca/biosketch-francesc-bosch-3/2022-06-30always0.5 https://vhio.net/es/biosketch-teresa-macarulla-2/2022-06-30always0.5 https://vhio.net/ca/biosketch-teresa-macarulla-3/2022-06-30always0.5 https://vhio.net/es/biosketch-joaquin-arribas-2/2022-06-30always0.5 https://vhio.net/ca/biosketch-joaquin-arribas-3/2022-06-30always0.5 https://vhio.net/es/biosketch-raquel-perez-lopez-2/2022-06-30always0.5 https://vhio.net/ca/biosketch-raquel-perez-lopez-3/2022-06-30always0.5 https://vhio.net/mec-category/scientific-seminars/2022-06-30always0.5 https://vhio.net/es/vhio-ciclo-de-seminarios-cientificos-de-caixaresearch/2022-06-30always0.5 https://vhio.net/ca/vhio-cicle-de-seminaris-cientifics-de-caixaresearch/2022-06-30always0.5 https://vhio.net/es/benchstorming-seminars-3/2022-06-30always0.5 https://vhio.net/ca/benchstorming-seminars-2/2022-06-30always0.5 https://vhio.net/es/cursos-y-talleres/2022-06-30always0.5 https://vhio.net/ca/cursos-i-tallers/2022-06-30always0.5 https://vhio.net/contratacion-publica/2022-06-30always0.5 https://vhio.net/actividad-subvencional/2022-06-30always0.5 https://vhio.net/wp-content/uploads/2021/10/Institutional-Statement-on-the-use-of-research-animals.pdf2022-06-30always0.5 https://vhio.net/es/biosketch-josep-tabernero-es/2022-06-30always0.5 https://vhio.net/es/biosketch-andres-de-kelety-2/2022-06-30always0.5 https://vhio.net/es/biosketch-sergi-cuadrado-2/2022-06-30always0.5 https://vhio.net/es/biosketch-alejandro-piris-3/2022-06-30always0.5 https://vhio.net/es/biosketch-bianca-pont-2/2022-06-30always0.5 https://vhio.net/es/2021/07/27/los-probody-una-nueva-forma-de-hacer-mas-segura-la-inmunoterapia/2022-06-30always0.5 https://vhio.net/es/2022/02/02/enriqueta-felip-seleccionada-como-finalista-al-premio-vanguardia-de-la-ciencia/2022-06-30always0.5 https://vhio.net/es/biosketch-tian-tian-2/2022-06-30always0.5 https://vhio.net/es/biosketch-violeta-sierra-2/2022-06-30always0.5 https://vhio.net/es/biosketch-joan-seoane-2/2022-06-30always0.5 https://vhio.net/es/2022/02/21/omomyc-demuestra-por-primera-vez-su-capacidad-antimetastasica-en-el-cancer-de-mama/2022-06-30always0.5 https://vhio.net/es/biosketch-laura-soucek-2/2022-06-30always0.5 https://vhio.net/es/biosketch-jonathan-whitfield-2/2022-06-30always0.5 https://vhio.net/es/biosketch-joaquin-mateo-2/2022-06-30always0.5 https://vhio.net/es/biosketch-nicolas-herranz-2/2022-06-30always0.5 https://vhio.net/es/biosketch-cesar-serrano-2/2022-06-30always0.5 https://vhio.net/es/biosketch-hector-g-palmer-2/2022-06-30always0.5 https://vhio.net/es/biosketch-isabel-puig-borrell-2/2022-06-30always0.5 https://vhio.net/es/biosketch-jordi-martinez-2/2022-06-30always0.5 https://vhio.net/es/biosketch-josep-villanueva-2/2022-06-30always0.5 https://vhio.net/es/biosketch-cristina-saura-2/2022-06-30always0.5 https://vhio.net/es/biosketch-elena-garralda-2/2022-06-30always0.5 https://vhio.net/es/biosketch-marta-crespo-2/2022-06-30always0.5 https://vhio.net/es/2021/07/12/los-cambios-en-el-sistema-inmunologico-pueden-explicar-la-progresion-en-la-leucemia-linfocitica-cronica/2022-06-30always0.5 https://vhio.net/es/biosketch-elena-elez-3/2022-06-30always0.5 https://vhio.net/es/biosketch-jaume-capdevila-2/2022-06-30always0.5 https://vhio.net/es/biosketch-joan-carles-2/2022-06-30always0.5 https://vhio.net/es/biosketch-rafael-morales-2/2022-06-30always0.5 https://vhio.net/es/biosketch-cristina-suarez-2/2022-06-30always0.5 https://vhio.net/es/biosketch-claudia-valverde-2/2022-06-30always0.5 https://vhio.net/es/biosketch-ana-oaknin-2/2022-06-30always0.5 https://vhio.net/es/2022/06/27/una-guia-de-practica-clinica-de-esmo-para-el-cancer-de-endometrio-propone-un-nuevo-algoritmo-terapeutico-basado-en-la-clasificacion-molecular/2022-06-30always0.5 https://vhio.net/es/biosketch-judith-balmana-2/2022-06-30always0.5 https://vhio.net/es/biosketch-sara-gutierrez-2/2022-06-30always0.5 https://vhio.net/es/biosketch-rodrigo-dientsmann-2/2022-06-30always0.5 https://vhio.net/es/biosketch-jordi-giralt-2/2022-06-30always0.5 https://vhio.net/es/biosketch-kinga-bernatowicz-2/2022-06-30always0.5 https://vhio.net/es/biosketch-francesco-grussu-2/2022-06-30always0.5 https://vhio.net/es/biosketch-alonso-garcia-ruiz-2/2022-06-30always0.5 https://vhio.net/es/biosketch-marta-ligero-2/2022-06-30always0.5 https://vhio.net/es/biosketch-olivia-prior-palomares-2/2022-06-30always0.5 https://vhio.net/es/biosketch-camilo-monreal-2/2022-06-30always0.5 https://vhio.net/es/biosketch-carlos-macarro-2/2022-06-30always0.5 https://vhio.net/es/biosketch-iker-zubieta-2/2022-06-30always0.5 https://vhio.net/es/biosketch-maria-balaguer-2/2022-06-30always0.5 https://vhio.net/es/biosketch-andreu-antolin-2/2022-06-30always0.5 https://vhio.net/es/biosketch-enriqueta-felip-2/2022-06-30always0.5 https://vhio.net/es/2021/10/22/la-dra-enriqueta-felip-del-vhio-nueva-presidenta-de-seom/2022-06-30always0.5 https://vhio.net/es/biosketch-lara-nonell-2/2022-06-30always0.5 https://vhio.net/es/biosketch-ana-vivancos-2/2022-06-30always0.5 https://vhio.net/es/biosketch-paolo-g-nuciforo-2/2022-06-30always0.5 https://vhio.net/es/biosketch-francesc-canals-2/2022-06-30always0.5 https://vhio.net/es/2021/06/10/vhio-participa-en-una-unidad-de-proteomica-biomedica-liderada-por-el-irb-barcelona-para-avanzar-hacia-la-medicina-personalizada/2022-06-30always0.5 https://vhio.net/es/biosketch-susanna-aguilar-2/2022-06-30always0.5 https://vhio.net/es/biosketch-maria-abad-2/2022-06-30always0.5 https://vhio.net/es/biosketch-meritxell-bellet-2/2022-06-30always0.5 https://vhio.net/es/biosketch-orland-diez-2/2022-06-30always0.5 https://vhio.net/es/biosketch-eva-munoz-2/2022-06-30always0.5 https://vhio.net/es/biosketch-mafalda-oliveira-2/2022-06-30always0.5 https://vhio.net/es/biosketch-marta-beltran-3/2022-06-30always0.5 https://vhio.net/es/biosketch-susana-munoz-3/2022-06-30always0.5 https://vhio.net/es/biosketch-isabel-cidoncha-2/2022-06-30always0.5 https://vhio.net/es/biosketch-maria-queralt-gorgas-3/2022-06-30always0.5 https://vhio.net/es/biosketch-gemma-sala-3/2022-06-30always0.5 https://vhio.net/es/biosketch-imma-falero-2/2022-06-30always0.5 https://vhio.net/es/2022/06/09/un-nuevo-farmaco-inhibidor-de-braf-y-permeable-al-cerebro-demuestra-su-eficacia-preclinica-para-tratar-de-manera-mas-eficaz-la-metastasis-cerebral-causada-por-el-melanoma/2022-06-30always0.5 https://vhio.net/es/2022/06/07/dos-estudios-sobre-el-uso-de-inmunoterapia-en-el-tratamiento-de-pacientes-con-cancer-de-endometrio-y-de-cuello-uterino-avanzado-temas-destacados-de-vall-dhebron-en-asco-2022/2022-06-30always0.5 https://vhio.net/es/2022/06/06/vigex-una-herramienta-desarrollada-por-el-vhio-demuestra-su-utilidad-para-predecir-la-respuesta-a-la-inmunoterapia/2022-06-30always0.5 https://vhio.net/es/2022/06/06/vhio-presenta-novedades-sobre-el-cancer-de-mama-en-el-congreso-anual-de-asco/2022-06-30always0.5 https://vhio.net/es/2022/06/05/un-nuevo-tratamiento-es-eficaz-en-el-cancer-de-mama-avanzado-con-bajo-her2/2022-06-30always0.5 https://vhio.net/es/2022/06/05/la-uitm-caixaresearch-de-vhio-presenta-en-asco-avances-en-el-desarrollo-de-nuevos-farmacos/2022-06-30always0.5 https://vhio.net/es/2022/06/04/un-estudio-con-participacion-del-vhio-demuestra-la-utilidad-de-la-biopsia-liquida-en-el-manejo-de-pacientes-con-gist/2022-06-30always0.5 https://vhio.net/es/2022/06/03/un-estudio-en-el-que-ha-participado-vhio-confirma-que-la-magnitud-de-la-respuesta-al-tratamiento-se-correlaciona-con-mejores-resultados-en-pacientes-con-cancer-renal/2022-06-30always0.5 https://vhio.net/es/2022/06/03/vhio-participa-en-diferentes-estudios-que-avanzan-en-el-tratamiento-del-cancer-de-pulmon/2022-06-30always0.5 https://vhio.net/es/2022/06/01/vhio-participa-en-un-proyecto-europeo-para-universalizar-la-interpretacion-de-genomas-de-tumores-para-la-medicina-personalizada-del-cancer/2022-06-30always0.5 https://vhio.net/es/events__/como-llevar-una-alimentacion-mas-consciente-y-disfrutar-de-la-comida-saludable/2022-06-30always0.5 https://vhio.net/es/events__/oskar-marin-drug-resistance-mechanisms-and-cancer-cell-vulnerabilities-3/2022-06-30always0.5 https://vhio.net/es/events__/carlos-arteaga-i-fgfr-pathway-as-a-mechanism-of-resistance-to-endocrine-therapy-in-breast-cancer/2022-06-30always0.5 https://vhio.net/es/events__/daniel-medina-targeting-tumor-immune-microenvironment-interactions-for-the-treatment-of-mature-b-cell-malignancies/2022-06-30always0.5 https://vhio.net/es/category/es_news-es/2022-06-30always0.5 https://vhio.net/es/tag/astrazeneca/2022-06-30always0.5 https://vhio.net/es/tag/dr-baselga/2022-06-30always0.5 https://vhio.net/es/tag/dr-tabernero/2022-06-30always0.5 https://vhio.net/es/tag/investigacion-preclinica/2022-06-30always0.5 https://vhio.net/es/tag/investigacion-traslacional/2022-06-30always0.5 https://vhio.net/es/tag/jose-baselga/2022-06-30always0.5 https://vhio.net/es/tag/josep-tabernero-es/2022-06-30always0.5 https://vhio.net/es/tag/partner-of-choicec/2022-06-30always0.5 https://vhio.net/es/tag/tabernero-es/2022-06-30always0.5 https://vhio.net/es/tag/alena-gros-es/2022-06-30always0.5 https://vhio.net/es/tag/bbva-es/2022-06-30always0.5 https://vhio.net/es/tag/elena-garralda-es/2022-06-30always0.5 https://vhio.net/es/tag/til-es/2022-06-30always0.5 https://vhio.net/es/tag/uitm-es/2022-06-30always0.5 https://vhio.net/es/tag/vhio-bbva-foundation-comprehensive-program-of-cancer-immunotherapy-immunology-caimi-es/2022-06-30always0.5 https://vhio.net/es/biosketch-jose-antonio-seoane-2/2022-06-30always0.5 https://vhio.net/ca/biosketch-cristina-saura-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-elena-garralda-3/2022-06-30always0.5 https://vhio.net/es/mec-category/scientific-seminars-es/2022-06-30always0.5 https://vhio.net/product/donate/2022-06-30always0.5 https://vhio.net/ca/biosketch-josep-tabernero-2/2022-06-30always0.5 https://vhio.net/ca/biosketch-andres-de-kelety-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-sergi-cuadrado-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-alejandro-piris-2/2022-06-30always0.5 https://vhio.net/ca/biosketch-bianca-pont-3/2022-06-30always0.5 https://vhio.net/ca/2021/07/27/els-probody-una-nova-forma-de-fer-mes-segura-la-immunoterapia/2022-06-30always0.5 https://vhio.net/ca/2022/01/25/vhio-participa-en-el-desenvolupament-del-primer-test-genomic-per-al-tractament-personalitzat-del-cancer-de-mama-her2/2022-06-30always0.5 https://vhio.net/ca/biosketch-jose-antonio-seoane-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-maria-abad-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-violeta-serra/2022-06-30always0.5 https://vhio.net/ca/biosketch-joan-seoane-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-laura-soucek-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-jonathan-whitfield-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-joaquin-mateo-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-nicolas-herranz-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-cesar-serrano-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-hector-g-palmer-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-isabel-puig-borrell-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-jordi-martinez-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-josep-villanueva-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-marta-crespo-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-elena-elez-2/2022-06-30always0.5 https://vhio.net/ca/biosketch-jaume-capdevila-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-joan-carles-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-rafael-morales-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-cristina-suarez-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-claudia-valverde-3/2022-06-30always0.5 https://vhio.net/ca/2021/07/12/els-canvis-en-el-sistema-immunologic-poden-explicar-la-progressio-en-la-leucemia-limfocitica-cronica/2022-06-30always0.5 https://vhio.net/ca/biosketch-ana-oaknin-3/2022-06-30always0.5 https://vhio.net/ca/2022/06/27/una-guia-de-practica-clinica-desmo-per-al-cancer-dendometri-proposa-un-nou-algorisme-terapeutic-basat-en-la-classificacio-molecular/2022-06-30always0.5 https://vhio.net/ca/biosketch-judith-balmana-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-sara-gutierrez-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-rodrigo-dientsmann-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-jordi-giralt-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-kinga-bernatowicz-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-francesco-grussu-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-alonso-garcia-ruiz-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-marta-ligero-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-olivia-prior-palomares-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-camilo-monreal-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-carlos-macarro-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-iker-zubieta-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-maria-balaguer-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-andreu-antolin-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-enriqueta-felip-3/2022-06-30always0.5 https://vhio.net/ca/2021/09/23/la-6a-sosciathlon-destinara-una-part-de-la-recaptacio-a-la-recerca-en-cancer-de-pulmo-al-vhio/2022-06-30always0.5 https://vhio.net/ca/2021/10/22/la-dra-enriqueta-felip-del-vhio-nova-presidenta-de-seom/2022-06-30always0.5 https://vhio.net/ca/2022/02/02/enriqueta-felip-seleccionada-com-a-finalista-al-premi-vanguardia-de-la-ciencia/2022-06-30always0.5 https://vhio.net/ca/biosketch-lara-nonell-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-ana-vivancos-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-paolo-g-nuciforo-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-francesc-canals-3/2022-06-30always0.5 https://vhio.net/ca/2022/01/26/vhio-participa-en-una-unitat-de-proteomica-biomedica-liderada-per-lirb-barcelona-per-avancar-cap-a-la-medicina-personalitzada/2022-06-30always0.5 https://vhio.net/ca/biosketch-susanna-aguilar-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-meritxell-bellet-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-orland-diez-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-eva-munoz-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-mafalda-oliveira-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-tian-tian-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-marta-beltran-2/2022-06-30always0.5 https://vhio.net/ca/biosketch-susana-munoz-2/2022-06-30always0.5 https://vhio.net/ca/biosketch-angeles-penuelas-2/2022-06-30always0.5 https://vhio.net/ca/biosketch-isabel-cidoncha-3/2022-06-30always0.5 https://vhio.net/ca/biosketch-maria-queralt-gorgas-2/2022-06-30always0.5 https://vhio.net/ca/biosketch-gemma-sala-2/2022-06-30always0.5 https://vhio.net/ca/biosketch-imma-falero-3/2022-06-30always0.5 https://vhio.net/ca/2022/06/07/dos-estudis-sobre-lus-dimmunoterapia-en-el-tractament-de-pacients-amb-cancer-dendometri-i-de-coll-uteri-avancat-temes-destacats-de-vall-dhebron-a-lasco-20/2022-06-30always0.5 https://vhio.net/ca/2022/06/06/vigex-una-eina-desenvolupada-pel-vhio-demostra-la-seva-utilitat-per-predir-la-resposta-a-la-immunoterapia/2022-06-30always0.5 https://vhio.net/ca/2022/06/06/vhio-presenta-novetats-sobre-el-cancer-de-mama-al-congres-anual-dasco/2022-06-30always0.5 https://vhio.net/ca/2022/06/05/un-nou-tractament-es-eficac-en-el-cancer-de-mama-avancat-amb-baix-her2/2022-06-30always0.5 https://vhio.net/ca/2022/06/05/la-uitm-caixaresearch-de-vhio-presenta-a-lasco-avencos-en-el-desenvolupament-de-nous-farmacs/2022-06-30always0.5 https://vhio.net/ca/2022/06/04/un-estudi-amb-participacio-del-vhio-demostra-la-utilitat-de-la-biopsia-liquida-en-el-maneig-de-pacients-amb-gist/2022-06-30always0.5 https://vhio.net/ca/2022/06/03/un-estudi-en-que-ha-participat-vhio-confirma-que-la-magnitud-de-la-resposta-al-tractament-es-correlaciona-amb-resultats-millors-en-pacients-amb-cancer-renal/2022-06-30always0.5 https://vhio.net/ca/2022/06/03/vhio-participa-en-diferents-estudis-que-avancen-en-el-tractament-del-cancer-de-pulmo/2022-06-30always0.5 https://vhio.net/ca/2022/06/01/vhio-participa-en-un-projecte-europeu-per-universalitzar-la-interpretacio-dels-genomes-de-tumors-per-a-la-medicina-personalitzada-del-cancer/2022-06-30always0.5 https://vhio.net/ca/2022/05/30/vhio-apropa-la-ciencia-del-cancer-a-la-ciutadania-participant-a-la-15a-festa-de-la-ciencia/2022-06-30always0.5 https://vhio.net/ca/events__/como-llevar-una-alimentacion-mas-consciente-y-disfrutar-de-la-comida-saludable-3/2022-06-30always0.5 https://vhio.net/ca/events__/oskar-marin-drug-resistance-mechanisms-and-cancer-cell-vulnerabilities/2022-06-30always0.5 https://vhio.net/ca/events__/i-mei-siu-i-an-introduction-to-cancer-discovery/2022-06-30always0.5 https://vhio.net/ca/events__/alba-escriche-impact-of-therapy-induced-senescence-on-the-tumor-microenvironment-carmen-escudero-novel-therapeutic-strategies-for-nut-midline-carcinoma-3/2022-06-30always0.5 https://vhio.net/ca/category/ca_news-ca/2022-06-30always0.5 https://vhio.net/ca/tag/alena-gros-ca/2022-06-30always0.5 https://vhio.net/ca/tag/bbva-ca/2022-06-30always0.5 https://vhio.net/ca/tag/elena-garralda-ca/2022-06-30always0.5 https://vhio.net/ca/tag/til-ca/2022-06-30always0.5 https://vhio.net/ca/tag/uitm-ca/2022-06-30always0.5 https://vhio.net/ca/tag/vhio-bbva-foundation-comprehensive-program-of-cancer-immunotherapy-immunology-caimi-ca/2022-06-30always0.5 https://vhio.net/ca/tag/josep-tabernero-ca/2022-06-30always0.5 https://vhio.net/ca/tag/recerca-translacional/2022-06-30always0.5 https://vhio.net/ca/tag/brafc1acancer-researchjoan-seoanemelanomametastasi-cerebraluitm-caixaresearch-ca/2022-06-30always0.5 https://vhio.net/ca/mec-category/scientific-seminars-ca/2022-06-30always0.5 https://vhio.net/tag/growth-factors-group/2022-06-30always0.5 https://vhio.net/tag/joaquin-arribas/2022-06-30always0.5 https://vhio.net/tag/vhio-bbva-foundation-comprehensive-program-of-cancer-immunotherapy-immunology-caimi/2022-06-30always0.5 https://vhio.net/tag/caixaresearch-advanced-oncology-research-program/2022-06-30always0.5 https://vhio.net/tag/elena-garralda/2022-06-30always0.5 https://vhio.net/tag/esmo-perspectives/2022-06-30always0.5 https://vhio.net/2021/12/31/emerging-approaches-for-treating-gastroesophageal-adenocarcinoma-the-pitfalls-progress-promise-ahead/2022-06-30always0.5 https://vhio.net/tag/oncology/2022-06-30always0.5 https://vhio.net/tag/tumor-metabolism/2022-06-30always0.5 https://vhio.net/category/news/2022-06-30always0.5 https://vhio.net/tag/mtb/2022-06-30always0.5 https://vhio.net/tag/on-target/2022-06-30always0.5 https://vhio.net/tag/uitm/2022-06-30always0.5 https://vhio.net/2021/03/24/the-passing-of-a-visionary-in-cancer-research-and-clinical-oncology-jose-baselga-1959-2021/2022-06-30always0.5 https://vhio.net/tag/laura-soucek/2022-06-30always0.5 https://vhio.net/tag/radiomics-group/2022-06-30always0.5 https://vhio.net/tag/raquel-perez-lopez/2022-06-30always0.5 https://vhio.net/2021/01/08/a-step-forward-in-the-validation-of-reliable-preclinical-models-for-cancer-research/2022-06-30always0.5 https://vhio.net/tag/ana-vivancos/2022-06-30always0.5 https://vhio.net/tag/cancer-genomics-group/2022-06-30always0.5 https://vhio.net/tag/fero-foundations-advanced-molecular-diagnostics-program/2022-06-30always0.5 https://vhio.net/tag/oncology-data-science-odyssey-group/2022-06-30always0.5 https://vhio.net/tag/prescreening-program/2022-06-30always0.5 https://vhio.net/tag/rodrigo-dientsmann/2022-06-30always0.5 https://vhio.net/tag/susana-aguilar/2022-06-30always0.5 https://vhio.net/tag/gene-expression-and-cancer-group/2022-06-30always0.5 https://vhio.net/tag/joan-seoane/2022-06-30always0.5 https://vhio.net/tag/molecular-oncology-group/2022-06-30always0.5 https://vhio.net/tag/paolo-nuciforo/2022-06-30always0.5 https://vhio.net/tag/jonathan-whitfield/2022-06-30always0.5 https://vhio.net/tag/maria-abad/2022-06-30always0.5